FluroTech Ltd. (FLURF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | - CAD | 100.0% |
| 2022 | -147.27 Thousand CAD | -43.91% |
| 2021 | -102.33 Thousand CAD | -138.8% |
| 2020 | -42.85 Thousand CAD | -134.13% |
| 2019 | 125.56 Thousand CAD | 242.55% |
| 2018 | -88.07 Thousand CAD | -1098.52% |
| 2017 | -7349.00 CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | - CAD | 0.0% |
| 2024 Q2 | - CAD | 0.0% |
| 2023 Q4 | - CAD | 0.0% |
| 2023 Q3 | - CAD | 0.0% |
| 2023 Q2 | - CAD | 0.0% |
| 2023 FY | - CAD | 100.0% |
| 2023 Q1 | - CAD | 100.0% |
| 2022 Q1 | -39.04 Thousand CAD | 2.25% |
| 2022 Q3 | -39.8 Thousand CAD | -1.91% |
| 2022 Q2 | -39.05 Thousand CAD | -0.03% |
| 2022 FY | -147.27 Thousand CAD | -43.91% |
| 2022 Q4 | -29.37 Thousand CAD | 26.2% |
| 2021 FY | -102.33 Thousand CAD | -138.8% |
| 2021 Q3 | -38.26 Thousand CAD | -161.27% |
| 2021 Q4 | -39.94 Thousand CAD | -4.39% |
| 2021 Q1 | -9492.00 CAD | 94.39% |
| 2021 Q2 | -14.64 Thousand CAD | -54.28% |
| 2020 Q3 | 15.76 Thousand CAD | -1.19% |
| 2020 Q4 | -169.17 Thousand CAD | -1173.28% |
| 2020 Q1 | 16.85 Thousand CAD | -80.83% |
| 2020 FY | -42.85 Thousand CAD | -134.13% |
| 2020 Q2 | 15.95 Thousand CAD | -5.36% |
| 2019 Q3 | 37.62 Thousand CAD | 0.0% |
| 2019 FY | 125.56 Thousand CAD | 242.55% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q4 | 87.93 Thousand CAD | 133.68% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 FY | -88.07 Thousand CAD | -1098.52% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 FY | -7349.00 CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AVITA Medical, Inc. | 41.68 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 100.0% |
| Össur hf. | 485.57 Million USD | 100.0% |
| QHSLab, Inc. | 793.6 Thousand USD | 100.0% |
| Wellstar International, Inc. | - USD | NaN% |
| Össur hf. | 485.57 Million USD | 100.0% |
| CVR Medical Corp. | - USD | NaN% |
| Bionovate Technologies Corp | - USD | NaN% |
| Escalon Medical Corp. | 5.14 Million USD | 100.0% |
| Aurora Spine Corporation | 8.21 Million USD | 100.0% |
| BrainsWay Ltd. | 23.09 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| BioElectronics Corporation | 466.38 Thousand USD | 100.0% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 100.0% |
| Vivos Inc. | -6036.00 USD | 100.0% |
| Kelyniam Global, Inc. | 2.03 Million USD | 100.0% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 100.0% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 100.0% |
| Avitar, Inc. | 836.7 Thousand USD | 100.0% |
| Nanomix Corporation | -69.45 Thousand USD | 100.0% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 100.0% |
| Theraclion SA | -1.08 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Positron Corporation | -353.46 Thousand USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 1.04 Million USD | 100.0% |
| Lombard Medical, Inc. | 955 Thousand USD | 100.0% |
| ALR Technologies Inc. | 4945.00 USD | 100.0% |
| Stratec SE | 71.58 Million USD | 100.0% |
| Vycor Medical, Inc. | 1.31 Million USD | 100.0% |
| Heart Tronics, Inc. | - USD | NaN% |
| MicroPort Scientific Corporation | 532.09 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | -10.44 USD | 100.0% |
| NewCardio, Inc. | 105.1 Thousand USD | 100.0% |
| Guided Therapeutics, Inc. | 36 Thousand USD | 100.0% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | 100.0% |
| Odyssey Group International, Inc. | - USD | NaN% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | 100.0% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | 100.0% |
| SANUWAVE Health, Inc. | 14.36 Million USD | 100.0% |
| IR-Med Inc. | -17 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 100.0% |
| Polarean Imaging plc | 335.48 Thousand USD | 100.0% |
| United American Healthcare Corporation | -8000.00 USD | 100.0% |
| ECGI Holdings, Inc. | - USD | NaN% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 100.0% |
| Capital Group Holdings, Inc. | - USD | NaN% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 1.75 Million USD | 100.0% |
| Urologix, Inc. | 6.09 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | NaN% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 100.0% |
| SS Innovations International, Inc. | 713.44 Thousand USD | 100.0% |
| Qualis Innovations, Inc. | - USD | NaN% |
| Smith & Nephew plc | 3.91 Billion USD | 100.0% |
| NIOX Group Plc | 28.13 Million USD | 100.0% |
| Fuse Medical, Inc. | 10.73 Million USD | 100.0% |
| Broncus Holding Corporation | 7.22 Million USD | 100.0% |
| Brain Scientific Inc. | 54.32 Thousand USD | 100.0% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | 100.0% |
| Health Logic Interactive Inc. | - USD | NaN% |